Cluster Gauss–Newton method
暂无分享,去创建一个
Ken Hayami | Yasunori Aoki | Kota Toshimoto | Yuichi Sugiyama | K. Hayami | K. Toshimoto | Yuichi Sugiyama | Yasunori Aoki | Kota Toshimoto
[1] Yuichi Sugiyama,et al. Virtual Clinical Studies to Examine the Probability Distribution of the AUC at Target Tissues Using Physiologically-Based Pharmacokinetic Modeling: Application to Analyses of the Effect of Genetic Polymorphism of Enzymes and Transporters on Irinotecan Induced Side Effects , 2017, Pharmaceutical Research.
[2] P. Hansen. Rank-Deficient and Discrete Ill-Posed Problems: Numerical Aspects of Linear Inversion , 1987 .
[3] C. T. Kelley,et al. Implicit Filtering , 2011 .
[4] Alexander H. G. Rinnooy Kan,et al. A stochastic method for global optimization , 1982, Math. Program..
[5] Riccardo Poli,et al. Particle swarm optimization , 1995, Swarm Intelligence.
[6] Keisuke Kakimoto,et al. Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism. , 2017, Journal of pharmaceutical sciences.
[7] Lawrence F. Shampine,et al. The MATLAB ODE Suite , 1997, SIAM J. Sci. Comput..
[8] Kazuya Maeda,et al. Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans , 2009, Journal of Pharmacology and Experimental Therapeutics.
[9] Michel Bierlaire,et al. Solving Noisy, Large-Scale Fixed-Point Problems and Systems of Nonlinear Equations , 2006, Transp. Sci..
[10] K. Maeda,et al. Quantitative Analyses of Hepatic OATP‐Mediated Interactions Between Statins and Inhibitors Using PBPK Modeling With a Parameter Optimization Method , 2016, Clinical pharmacology and therapeutics.
[11] Hans-Martin Gutmann,et al. A Radial Basis Function Method for Global Optimization , 2001, J. Glob. Optim..
[12] Stefan M. Wild. Chapter 40: POUNDERS in TAO: Solving Derivative-Free Nonlinear Least-Squares Problems with POUNDERS , 2017 .
[13] Coralia Cartis,et al. A derivative-free Gauss–Newton method , 2017, Mathematical Programming Computation.
[14] Yuichi Sugiyama,et al. Quantitative Analysis of Complex Drug-Drug Interactions between Cerivastatin and Metabolism/Transport Inhibitors Using Physiologically Based Pharmacokinetic Modeling , 2018, Drug Metabolism and Disposition.
[15] R. Fletcher,et al. A New Approach to Variable Metric Algorithms , 1970, Comput. J..
[16] C. Gauss. Theory of the Motion of the Heavenly Bodies Moving About the Sun in Conic Sections , 1957 .
[17] Coralia Cartis,et al. Improving the Flexibility and Robustness of Model-based Derivative-free Optimization Solvers , 2018, ACM Trans. Math. Softw..
[18] Carlos A. Coello Coello,et al. Constraint-handling in nature-inspired numerical optimization: Past, present and future , 2011, Swarm Evol. Comput..
[19] D. Shanno. Conditioning of Quasi-Newton Methods for Function Minimization , 1970 .
[20] Akihiko Konagaya,et al. Cluster Newton Method for Sampling Multiple Solutions of Underdetermined Inverse Problems: Application to a Parameter Identification Problem in Pharmacokinetics , 2014, SIAM J. Sci. Comput..
[21] V. Eyert. A Comparative Study on Methods for Convergence Acceleration of Iterative Vector Sequences , 1996 .
[22] J. Swarbrick. Drugs and the pharmaceutical sciences , 1975 .
[23] Stefan M. Wild,et al. Derivative-free optimization methods , 2019, Acta Numerica.
[24] Akihiko Konagaya,et al. Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model , 2017, BMC Systems Biology.
[25] David E. Goldberg,et al. Genetic algorithms and Machine Learning , 1988, Machine Learning.
[26] Jorge J. Moré,et al. The Levenberg-Marquardt algo-rithm: Implementation and theory , 1977 .
[27] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[28] Jason E. Hicken,et al. Error-tolerant Multisecant Method for Nonlinearly Constrained Optimization , 2017, 1709.06985.
[29] C. D. Perttunen,et al. Lipschitzian optimization without the Lipschitz constant , 1993 .
[30] Akihiko Konagaya,et al. Cluster newton method for sampling multiple solutions of an underdetermined inverse problem: Parameter identification for pharmacokinetics , 2011 .
[31] Akihiko Konagaya,et al. Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models , 2013, BMC Systems Biology.
[32] Hans Petter Langtangen,et al. Chaospy: An open source tool for designing methods of uncertainty quantification , 2015, J. Comput. Sci..
[33] D. Shanno,et al. Optimal conditioning of quasi-Newton methods , 1970 .
[34] Patrick R. Amestoy,et al. On Exploiting Sparsity of Multiple Right-Hand Sides in Sparse Direct Solvers , 2019, SIAM J. Sci. Comput..
[35] Yuichi Sugiyama,et al. Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype‐Guided Dosing of Tamoxifen , 2018, CPT: pharmacometrics & systems pharmacology.
[36] Yuichi Sugiyama,et al. Quantitative Analysis of Complex Drug-Drug Interactions Between Repaglinide and Cyclosporin A/Gemfibrozil Using Physiologically Based Pharmacokinetic Models With In Vitro Transporter/Enzyme Inhibition Data. , 2017, Journal of pharmaceutical sciences.
[37] D. Goldfarb. A family of variable-metric methods derived by variational means , 1970 .
[38] C. G. Broyden. The Convergence of a Class of Double-rank Minimization Algorithms 1. General Considerations , 1970 .
[39] D. Marquardt. An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .
[40] Nicholas I. M. Gould,et al. Trust Region Methods , 2000, MOS-SIAM Series on Optimization.